Transfusion

Cover image for Vol. 52 Issue 10

October 2012

Volume 52, Issue 10

Pages 2071–2275

  1. In this issue

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. HOW DO I … ?
    5. TRANSFUSION MEDICINE ILLUSTRATED
    6. BLOOD COMPONENTS
    7. TRANSFUSION COMPLICATIONS
    8. TRANSFUSION PRACTICE
    9. BLOOD MANAGEMENT
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. IMMUNOHEMATOLOGY
    13. TRANSPLANTATION AND CELLULAR ENGINEERING
    14. REVIEW
    15. OBITUARY
    16. LETTERS TO THE EDITOR
    1. In this issue (page 2071)

      Version of Record online: 30 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03341.x

  2. EDITORIALS

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. HOW DO I … ?
    5. TRANSFUSION MEDICINE ILLUSTRATED
    6. BLOOD COMPONENTS
    7. TRANSFUSION COMPLICATIONS
    8. TRANSFUSION PRACTICE
    9. BLOOD MANAGEMENT
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. IMMUNOHEMATOLOGY
    13. TRANSPLANTATION AND CELLULAR ENGINEERING
    14. REVIEW
    15. OBITUARY
    16. LETTERS TO THE EDITOR
    1. Immunoglobulin therapy and thrombosis: coincidence or causation? (pages 2075–2077)

      Douglass A. Drelich, Paul F. Bray and Jay H. Herman

      Version of Record online: 30 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03868.x

  3. HOW DO I … ?

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. HOW DO I … ?
    5. TRANSFUSION MEDICINE ILLUSTRATED
    6. BLOOD COMPONENTS
    7. TRANSFUSION COMPLICATIONS
    8. TRANSFUSION PRACTICE
    9. BLOOD MANAGEMENT
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. IMMUNOHEMATOLOGY
    13. TRANSPLANTATION AND CELLULAR ENGINEERING
    14. REVIEW
    15. OBITUARY
    16. LETTERS TO THE EDITOR
    1. How we treat: risk mitigation for ABO-incompatible plasma in plateletpheresis products (pages 2081–2085)

      Magali J. Fontaine, Anne M. Mills, Susan Weiss, Wan-Jen Hong, Maurene Viele and Lawrence T. Goodnough

      Version of Record online: 13 MAR 2012 | DOI: 10.1111/j.1537-2995.2012.03596.x

  4. TRANSFUSION MEDICINE ILLUSTRATED

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. HOW DO I … ?
    5. TRANSFUSION MEDICINE ILLUSTRATED
    6. BLOOD COMPONENTS
    7. TRANSFUSION COMPLICATIONS
    8. TRANSFUSION PRACTICE
    9. BLOOD MANAGEMENT
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. IMMUNOHEMATOLOGY
    13. TRANSPLANTATION AND CELLULAR ENGINEERING
    14. REVIEW
    15. OBITUARY
    16. LETTERS TO THE EDITOR
    1. The blood of a poet is irreplaceable (page 2086)

      Jean-Jacques Lefrère and Muriel Louâpre

      Version of Record online: 30 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03602.x

  5. BLOOD COMPONENTS

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. HOW DO I … ?
    5. TRANSFUSION MEDICINE ILLUSTRATED
    6. BLOOD COMPONENTS
    7. TRANSFUSION COMPLICATIONS
    8. TRANSFUSION PRACTICE
    9. BLOOD MANAGEMENT
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. IMMUNOHEMATOLOGY
    13. TRANSPLANTATION AND CELLULAR ENGINEERING
    14. REVIEW
    15. OBITUARY
    16. LETTERS TO THE EDITOR
    1. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions (pages 2087–2093)

      Matthew S. Karafin, Lorraine Blagg, Aaron A.R. Tobian, Karen E. King, Paul M. Ness and William J. Savage

      Version of Record online: 17 FEB 2012 | DOI: 10.1111/j.1537-2995.2012.03574.x

    2. Pathogen reduction treatment of buffy coat platelet concentrates in additive solution induces proapoptotic signaling (pages 2094–2103)

      Samantha Reid, Lacey Johnson, Narelle Woodland and Denese C. Marks

      Version of Record online: 10 FEB 2012 | DOI: 10.1111/j.1537-2995.2011.03558.x

    3. Pathogen safety of human C1 esterase inhibitor concentrate (pages 2104–2112)

      Albrecht Gröner, Thomas Nowak and Wolfram Schäfer

      Version of Record online: 13 MAR 2012 | DOI: 10.1111/j.1537-2995.2012.03590.x

  6. TRANSFUSION COMPLICATIONS

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. HOW DO I … ?
    5. TRANSFUSION MEDICINE ILLUSTRATED
    6. BLOOD COMPONENTS
    7. TRANSFUSION COMPLICATIONS
    8. TRANSFUSION PRACTICE
    9. BLOOD MANAGEMENT
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. IMMUNOHEMATOLOGY
    13. TRANSPLANTATION AND CELLULAR ENGINEERING
    14. REVIEW
    15. OBITUARY
    16. LETTERS TO THE EDITOR
    1. Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010 (pages 2113–2121)

      Gregory W. Daniel, Mikhail Menis, Gayathri Sridhar, Dorothy Scott, Anna E. Wallace, Mikhail V. Ovanesov, Basil Golding, Steven A. Anderson, Jay Epstein, David Martin, Robert Ball and Hector S. Izurieta

      Version of Record online: 11 MAR 2012 | DOI: 10.1111/j.1537-2995.2012.03589.x

    2. Chikungunya virus and the safety of plasma products (pages 2122–2130)

      Sandra M. Leydold, Maria R. Farcet, Johanna Kindermann, Jens Modrof, Gerhard Pölsler, Andreas Berting, M. Keith Howard, P. Noel Barrett and Thomas R. Kreil

      Version of Record online: 17 FEB 2012 | DOI: 10.1111/j.1537-2995.2012.03565.x

  7. TRANSFUSION PRACTICE

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. HOW DO I … ?
    5. TRANSFUSION MEDICINE ILLUSTRATED
    6. BLOOD COMPONENTS
    7. TRANSFUSION COMPLICATIONS
    8. TRANSFUSION PRACTICE
    9. BLOOD MANAGEMENT
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. IMMUNOHEMATOLOGY
    13. TRANSPLANTATION AND CELLULAR ENGINEERING
    14. REVIEW
    15. OBITUARY
    16. LETTERS TO THE EDITOR
    1. Economic impact on US Medicare of a new diagnosis of myelodysplastic syndromes and the incremental costs associated with blood transfusion need (pages 2131–2138)

      Stuart L. Goldberg, Er Chen, Medha Sasane, Carole Paley, Amy Guo and Marianne Laouri

      Version of Record online: 9 APR 2012 | DOI: 10.1111/j.1537-2995.2012.03626.x

    2. Incomplete pretransfusion testing leads to surgical delays (pages 2139–2144)

      Brian McWilliams, Mark H. Yazer, James Cramer, Darrell J. Triulzi and Jonathan H. Waters

      Version of Record online: 20 FEB 2012 | DOI: 10.1111/j.1537-2995.2012.03568.x

    3. Continuing Medical Education Program in Transfusion (page 2145)

      Anne F. Eder

      Version of Record online: 30 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03914.x

    4. The impact of beta-blocker therapy on anemia after traumatic brain injury (pages 2155–2160)

      Nina E. Glass, Lisa A. Kaltenbach, Sloan B. Fleming, Patrick G. Arbogast and Bryan A. Cotton

      Version of Record online: 15 MAR 2012 | DOI: 10.1111/j.1537-2995.2012.03609.x

    5. Blood transfusion practice in a rural hospital in Northern Ghana, Damongo, West Gonja District (pages 2161–2166)

      Chrysantus Kubio, Geraldine Tierney, Theophilus Quaye, James Wewoli Nabilisi, Callistus Ziemah, Sr Mary Zagbeeb, Sandra Shaw and William G. Murphy

      Version of Record online: 21 MAY 2012 | DOI: 10.1111/j.1537-2995.2012.03709.x

  8. BLOOD MANAGEMENT

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. HOW DO I … ?
    5. TRANSFUSION MEDICINE ILLUSTRATED
    6. BLOOD COMPONENTS
    7. TRANSFUSION COMPLICATIONS
    8. TRANSFUSION PRACTICE
    9. BLOOD MANAGEMENT
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. IMMUNOHEMATOLOGY
    13. TRANSPLANTATION AND CELLULAR ENGINEERING
    14. REVIEW
    15. OBITUARY
    16. LETTERS TO THE EDITOR
    1. Blood salvage and cancer surgery: a meta-analysis of available studies (pages 2167–2173)

      Jonathan H. Waters, Mark Yazer, Yi-Fan Chen and John Kloke

      Version of Record online: 10 FEB 2012 | DOI: 10.1111/j.1537-2995.2011.03555.x

  9. BLOOD DONORS AND BLOOD COLLECTION

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. HOW DO I … ?
    5. TRANSFUSION MEDICINE ILLUSTRATED
    6. BLOOD COMPONENTS
    7. TRANSFUSION COMPLICATIONS
    8. TRANSFUSION PRACTICE
    9. BLOOD MANAGEMENT
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. IMMUNOHEMATOLOGY
    13. TRANSPLANTATION AND CELLULAR ENGINEERING
    14. REVIEW
    15. OBITUARY
    16. LETTERS TO THE EDITOR
    1. Cardiovascular disease risk assessment and prevention in blood donors (pages 2174–2182)

      Debra A. Kessler, Caroline Ortiz, Kathleen Grima, David Vlahov, Vijay Nandi, Robert Jones, Christopher D. Hillyer and Beth H. Shaz

      Version of Record online: 10 FEB 2012 | DOI: 10.1111/j.1537-2995.2011.03549.x

    2. Switching iron-deficient whole blood donors to plateletpheresis (pages 2183–2188)

      Alix O'Meara, Laura Infanti, Jörg Sigle, Martin Stern and Andreas Buser

      Version of Record online: 8 MAR 2012 | DOI: 10.1111/j.1537-2995.2012.03584.x

    3. Blood donors' helping behavior is driven by warm glow: more evidence for the blood donor benevolence hypothesis (pages 2189–2200)

      Eamonn Ferguson, Michael Taylor, David Keatley, Niall Flynn and Claire Lawrence

      Version of Record online: 10 FEB 2012 | DOI: 10.1111/j.1537-2995.2011.03557.x

  10. DONOR INFECTIOUS DISEASE TESTING

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. HOW DO I … ?
    5. TRANSFUSION MEDICINE ILLUSTRATED
    6. BLOOD COMPONENTS
    7. TRANSFUSION COMPLICATIONS
    8. TRANSFUSION PRACTICE
    9. BLOOD MANAGEMENT
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. IMMUNOHEMATOLOGY
    13. TRANSPLANTATION AND CELLULAR ENGINEERING
    14. REVIEW
    15. OBITUARY
    16. LETTERS TO THE EDITOR
    1. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations (pages 2201–2208)

      Lynn A. Martin, Susan L. Stramer, Mary C. Kuhns and George G. Schlauder

      Version of Record online: 10 FEB 2012 | DOI: 10.1111/j.1537-2995.2011.03553.x

  11. IMMUNOHEMATOLOGY

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. HOW DO I … ?
    5. TRANSFUSION MEDICINE ILLUSTRATED
    6. BLOOD COMPONENTS
    7. TRANSFUSION COMPLICATIONS
    8. TRANSFUSION PRACTICE
    9. BLOOD MANAGEMENT
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. IMMUNOHEMATOLOGY
    13. TRANSPLANTATION AND CELLULAR ENGINEERING
    14. REVIEW
    15. OBITUARY
    16. LETTERS TO THE EDITOR
    1. CTLA4-Ig prevents alloantibody production and BMT rejection in response to platelet transfusions in mice (pages 2209–2219)

      Christopher R. Gilson, Seema R. Patel and James C. Zimring

      Version of Record online: 10 FEB 2012 | DOI: 10.1111/j.1537-2995.2011.03550.x

  12. TRANSPLANTATION AND CELLULAR ENGINEERING

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. HOW DO I … ?
    5. TRANSFUSION MEDICINE ILLUSTRATED
    6. BLOOD COMPONENTS
    7. TRANSFUSION COMPLICATIONS
    8. TRANSFUSION PRACTICE
    9. BLOOD MANAGEMENT
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. IMMUNOHEMATOLOGY
    13. TRANSPLANTATION AND CELLULAR ENGINEERING
    14. REVIEW
    15. OBITUARY
    16. LETTERS TO THE EDITOR
    1. Factors affecting the turnaround time for manufacturing, testing, and release of cellular therapy products prepared at multiple sites in support of multicenter cardiovascular regenerative medicine protocols: a Cardiovascular Cell Therapy Research Network (CCTRN) study (pages 2225–2233)

      Sara Richman, Adrian P. Gee, David H. McKenna, Jay H. Traverse, Timothy D. Henry, Diann Fisk, Carl J. Pepine, Jeannette Bloom, James T. Willerson, Karen Prater, David Zhao, Jane Reese Koç, Saif Anwaruddin, Doris A. Taylor, Christopher R. Cogle, Lemuel A. Moyé, Robert D. Simari and Sonia I. Skarlatos

      Version of Record online: 10 FEB 2012 | DOI: 10.1111/j.1537-2995.2011.03543.x

    2. Characteristics of thawed autologous umbilical cord blood (pages 2234–2242)

      Emma H. Rosenau, Michele W. Sugrue, Michael Haller, Diann Fisk, Susan S. Kelly, Myron Chang, Wei Hou, Lamis Eldjerou, William Slayton, Christopher R. Cogle and John R. Wingard

      Version of Record online: 10 FEB 2012 | DOI: 10.1111/j.1537-2995.2011.03556.x

  13. REVIEW

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. HOW DO I … ?
    5. TRANSFUSION MEDICINE ILLUSTRATED
    6. BLOOD COMPONENTS
    7. TRANSFUSION COMPLICATIONS
    8. TRANSFUSION PRACTICE
    9. BLOOD MANAGEMENT
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. IMMUNOHEMATOLOGY
    13. TRANSPLANTATION AND CELLULAR ENGINEERING
    14. REVIEW
    15. OBITUARY
    16. LETTERS TO THE EDITOR
  14. OBITUARY

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. HOW DO I … ?
    5. TRANSFUSION MEDICINE ILLUSTRATED
    6. BLOOD COMPONENTS
    7. TRANSFUSION COMPLICATIONS
    8. TRANSFUSION PRACTICE
    9. BLOOD MANAGEMENT
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. IMMUNOHEMATOLOGY
    13. TRANSPLANTATION AND CELLULAR ENGINEERING
    14. REVIEW
    15. OBITUARY
    16. LETTERS TO THE EDITOR
    1. Emanuel Hackel : 1925-2012 (page 2269)

      John A. Gerlach

      Version of Record online: 30 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03893.x

  15. LETTERS TO THE EDITOR

    1. Top of page
    2. In this issue
    3. EDITORIALS
    4. HOW DO I … ?
    5. TRANSFUSION MEDICINE ILLUSTRATED
    6. BLOOD COMPONENTS
    7. TRANSFUSION COMPLICATIONS
    8. TRANSFUSION PRACTICE
    9. BLOOD MANAGEMENT
    10. BLOOD DONORS AND BLOOD COLLECTION
    11. DONOR INFECTIOUS DISEASE TESTING
    12. IMMUNOHEMATOLOGY
    13. TRANSPLANTATION AND CELLULAR ENGINEERING
    14. REVIEW
    15. OBITUARY
    16. LETTERS TO THE EDITOR
    1. Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients (pages 2270–2272)

      Tammon Nash, Sandra Hoffmann, Suzanne Butch, Robertson Davenport and Laura Cooling

      Version of Record online: 30 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03739.x

    2. Does modern combat still need fresh whole blood transfusions? (pages 2272–2273)

      Sandra Henkelman and Gerhard Rakhorst

      Version of Record online: 30 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03749.x

    3. Comparison of source plasma quality in three different apheresis protocols (pages 2273–2275)

      Stephan T. Kießig, Knud-Peter Krause and Peter Hellstern

      Version of Record online: 30 OCT 2012 | DOI: 10.1111/j.1537-2995.2012.03753.x

SEARCH

SEARCH BY CITATION